| Reese–Ellsworth Group | Outcome of eyes (n = 44) | |||
| Enucleated before primary chemotherapy* | Enucleated after primary chemotherapy but before EBRT* | Enucleated after EBRT | Salvaged (percentage of group) | |
| Normal | 0 | 0 | 0 | 4 (100%) |
| I a | 0 | 0 | 0 | 4 (100%) |
| I b | 0 | 0 | 0 | 6 (100%) |
| II a | 0 | 0 | 0 | 3 (100%) |
| III a | 0 | 1 | 1 | 1 (33.3%) |
| III b | 0 | 2 | 0 | 2 (50.0%) |
| IV a | 0 | 1 | 2 | 5 (62.5%) |
| V a | 3 | 0 | 2 | 2 (28.6%) |
| V b | 1 | 0 | 1 | 3 (60.0%) |
*Eyes that were enucleated before external beam radiotherapy (EBRT) were not included in the analysis of the study.